Drug Alcohol Depend. 1998 Oct 1;52(2):167-71.

Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage.

D'Ippoliti D, Davoli M, Perucci CA, Pasqualini F, Bargagli AM.

Source

Department of Epidemiology, Lazio Regional Health Authority, Rome, Italy.

Abstract

Retention in treatment among 1503 heroin users attending public treatment centres in 1995 was studied. Three different treatments were considered: methadone maintenance, drug-free program and naltrexone. The retention rate after 1 year was 40% for patients in methadone maintenance, 18% in naltrexone and 15% in drug-free program. For patients in maintenance, methadone dosage and clinic policy were the most important factors for retention. Patients taking > or = 60 mg/day and 30-59 mg/day were respectively 70 and 50% more likely to remain in treatment than those receiving a < 30 mg daily dose. Patients in maintenance-oriented clinics were 30% more likely to remain in treatment than those in abstinence-oriented centres.

PMID:: 9800146; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Comparative Study

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Heroin - MedlinePlus Health Information

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation. [Arch Gen Psychiatry. 2008]
Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT, Tait RJ, Hulse GK. Arch Gen Psychiatry. 2008 Apr; 65(4):457-65.
Retention in a low-threshold methadone maintenance program. [Drug Alcohol Depend. 1996]
Retention in a low-threshold methadone maintenance program.
Torrens M, Castillo C, Pérez-Solá V. Drug Alcohol Depend. 1996 May; 41(1):55-9.
Retention in methadone maintenance and heroin addicts' risk of death. [Addiction. 1994]
Retention in methadone maintenance and heroin addicts' risk of death.
Caplehorn JR, Dalton MS, Cluff MC, Petrenas AM. Addiction. 1994 Feb; 89(2):203-9.
Review [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature]. [Encephale. 2009]
Review [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
Laqueille X, Launay C, Dervaux A, Kanit M. Encephale. 2009 Jun; 35(3):220-5. Epub 2008 Oct 1.
Review Heroin maintenance for chronic heroin dependents. [Cochrane Database Syst Rev. 2003]
Review Heroin maintenance for chronic heroin dependents.
Ferri M, Davoli M, Perucci CA. Cochrane Database Syst Rev. 2003; (4):CD003410.

See reviews... See all...

Cited by 7 PubMed Central articles

There is no age limit for methadone: a retrospective cohort study. [Subst Abuse Treat Prev Policy....]
There is no age limit for methadone: a retrospective cohort study.
Dürsteler-MacFarland KM, Vogel M, Wiesbeck GA, Petitjean SA. Subst Abuse Treat Prev Policy. 2011 May 18; 6:9. Epub 2011 May 18.
Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment. [BMC Health Serv Res. 2010]
Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment.
Gjersing L, Waal H, Caplehorn JR, Gossop M, Clausen T. BMC Health Serv Res. 2010 Jul 6; 10:194. Epub 2010 Jul 6.
Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment. [Br J Clin Pharmacol. 2009]
Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment.
Shiran MR, Lennard MS, Iqbal MZ, Lagundoye O, Seivewright N, Tucker GT, Rostami-Hodjegan A. Br J Clin Pharmacol. 2009 Jan; 67(1):29-37.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Retention in treatment of heroin users in Italy: the role of treatment type and ...
Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage.
Drug Alcohol Depend. 1998 Oct 1 ;52(2):167-71.

PubMed
[Volume replacement in critically ill intensive-care patients. No classic review...
[Volume replacement in critically ill intensive-care patients. No classic review].
Anaesthesist. 1998 Sep ;47(9):778-85.

PubMed
Neurocysticercosis.
Neurocysticercosis.
Postgrad Med J. 1998 Jun ;74(872):321-6.

PubMed
YAC rescue of downless locus mutations in mice.
YAC rescue of downless locus mutations in mice.
Mamm Genome. 1998 Nov ;9(11):863-8.

PubMed
Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsyc...
Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance.
Horm Behav. 1998 Oct ;34(2):171-82.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: